Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Study ID: NCT06660862
Start Date: 2026-11
End Date: 2029-11
Study Type

Interventional

Study Phase

Phase4

No. of Participants

80

Intervention / Treatment

Darolutamide

Physician choice Androgen Deprivation (Hormone) Therapy

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

Study ID: NCT07463703
Start Date: 2026-04
End Date: 2027-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Accelerated functional-connectivity guided transcranial magnetic stimulation

Sponsor

Cognitive FX

Source: clinicaltrials.gov

Share:
Add to list

Tigulixostat (IBI128) vs Febuxostat in Gout

Study ID: NCT07414394
Start Date: 2026-03-25
End Date: 2027-10-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Febuxostat

Tigulixostat

Sponsor

Innovent Biologics Technology Limited (Shanghai R&D Center)

Source: clinicaltrials.gov

Share:
Add to list

Thalamus Seizure Detection With a Deep Brain Stimulator System

Study ID: NCT06700356
Start Date: 2026-06-01
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5

Intervention / Treatment

Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring

Phase 2-DBS Stimulation with Medtronic Percept DBS device-Out Patient

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization

Study ID: NCT07304102
Start Date: 2026-09
End Date: 2032-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

GORE® EXCLUDER® IBE Plus Stent Graft

Sponsor

W.L.Gore & Associates

Source: clinicaltrials.gov

Share:
Add to list

A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer

Study ID: NCT07294339
Start Date: 2026-04-01
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

True Acupuncture

Sham Acupuncture

Sponsor

Peking University People's Hospital

Source: clinicaltrials.gov

Share:
Add to list

PANDORA: Evaluation of Platelet-rich Plasma in Non-tumoural Odour Disorders: a Descriptive Pilot Study.

Study ID: NCT07473830
Start Date: 2026-05
End Date: 2028-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Autologous Platelet-Rich Plasma (PRP) Injection

Sponsor

Civil Hospices of Lyon

Source: clinicaltrials.gov

Share:
Add to list

The Count Me In Program in Support of Social Participation for Older People With Loss of Autonomy

Study ID: NCT07440628
Start Date: 2026-04-01
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

8

Intervention / Treatment

The Count Me In Program

Sponsor

University of Quebec at Trois-Rivières

Source: clinicaltrials.gov

Share:
Add to list

Early Co-Administration of Crystalloid Fluid and Norepinephrine for Preventing Acute Kidney Injury in Septic Shock

Study ID: NCT07418541
Start Date: 2026-04-23
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Norepinephrine

Crystalloid Fluid Resuscitation

Sponsor

University of Northern Sumatra

Source: clinicaltrials.gov

Share:
Add to list

The Safety and Efficacy of XytriX in the Treatment of Knee Osteoarthritis

Study ID: NCT07487766
Start Date: 2026-05
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

XytriX, umbilical cord-derived mesenchymal stem cell

Sponsor

TricelX Inc.

Source: clinicaltrials.gov

Share:
Add to list